Dose and volume de-escalation for HPV-associated oropharyngeal cancer: Long-term follow-up of the OPTIMA trial.
Year: 2020
Type: conference-abstract
Source: Journal of Clinical Oncology
Institutions: University of Chicago, University of Chicago Medical Center
Language: English
Topic: Head and Neck Cancer Studies
Subfield: Otorhinolaryngology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funders: Celgene, National Institutes of Health
OpenAlex ID: W3029433769
